OL

Olivier De Lacharriere

LS L'Oreal S.A.: 32 patents #8 of 559Top 2%
L' L'Oreal: 15 patents #144 of 2,221Top 7%
Overall (All Time): #61,134 of 4,157,543Top 2%
47
Patents All Time

Issued Patents All Time

Showing 26–47 of 47 patents

Patent #TitleCo-InventorsDate
5958432 Cosmetic/pharmaceutical compositions comprising .beta.-adrenergic agonists/substance P antagonists Lionel Breton, Jacques Leclaire 1999-09-28
5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin Lionel Breton 1999-08-10
5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema Lionel Breton 1999-08-03
5902805 Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same Lionel Breton 1999-05-11
5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists Lionel Breton 1999-05-04
5900242 Cosmetic/dermatological skin care compositions comprising S-DHEA Lionel Breton 1999-05-04
5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists Lionel Breton 1999-04-20
5869068 Compositions and methods for treating wrinkles and/or fine lines of the skin Lionel Breton 1999-02-09
5866168 Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists Lionel Breton 1999-02-02
5858024 Composition for dyeing keratin fibres containing a substance P antagonist Lionel Breton, Geneviève Loussouarn 1999-01-12
5851556 Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained Lionel Breton 1998-12-22
5849312 Therapeutic/cosmetic compositions comprising bradykinin antagonist for treating sensitive human skin Lionel Breton 1998-12-15
5824650 Topical composition containing a substance P antagoinst Lionel Breton 1998-10-20
5803095 Permanent wave compositions comprising substance P/CGRP antagonists Geneviève Loussouarn, Lionel Breton 1998-09-08
5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it Lionel Breton, Lucien Aubert, Jacques Leclaire, Richard Martin 1998-08-18
5788956 Antiperspirant compositions comprising substance P antagonists Lionel Breton 1998-08-04
5744156 Use of a substance P antagonist for the treatment of skin reddening of neurogenic origin Lionel Breton 1998-04-28
5733558 Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same Lionel Breton 1998-03-31
5730998 Use of a substance P antagonist for the treatment of pruritus, ocular and/or palpebral pain and ocular or palpebral dysaesthesia Lionel Breton 1998-03-24
5714155 Ethylenediamine derivative in a cosmetic or dermatological composition, and composition containing in particular a product having an irritant side effect Jean-Baptiste Galey, Lionel Breton, Jacqueline Dumats 1998-02-03
5679360 Substance P antagonist for the treatment of lichens, prurigo, pruritus Lionel Breton 1997-10-21
5658581 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained Lionel Breton, Catherine Cohen 1997-08-19